genital renal anomalies, diabetes mellitus, steroids, trauma and major surgery, broad spectrum antibiotics, malignancy and its treatment (i.e. immunosuppression).
The proportion of male to female sufferers is 1:4. This is thought to be due to coincidental vaginal candidiasis, the shorter urethra in the female (Zincke et al. 1973) , and the distension of the ureters and pelvis in pregnancy.
Renal candidiasis can be a cause of hydronephrosis (Hurley & Winner 1963) . Yeast infections of the urinary tract are classified into 4 groups by Winner & Hurley in 1964: yeast septicmmia, systemic candidiases with selective renal involvement, ascending yeast urinary infections and mycotic urethritis. The diagnosis of renal candidiasis is made on the following findings:
Urine is turbid; it must contain yeasts in a colony count greater than 1000 per ml (Goldman etal. 1960) .
Cystoscopy reveals a diffuse or even ulcerative hamorrhagic inflammation. Irregular white patches are present which contain yeasts when biopsied. The ureteric orifices are red, cedematous and gaping (Goldman et al. 1960) . The mycelia form balls which can grow to large proportions and cause obstruction to bladder, ureters and kidneys.
Treatment: Moderate success has been achieved with nystatin bladder washouts (Kennelly 1965 , Cowan et al. 1962 , but this was not found in our case. Many reports have shown amphotericin B as a very effective local antifungal agent (Price et al. 1967 , Shelp et al. 1966 , Blum 1966 , Goldman etal. 1960 .
When given systemically amphotericin B isnephrotoxic and poorly excreted from the kidneys achieving low renal concentration. Noxyflex has been suggested as an effective local antifungal agent (Littlewood 1968) . I have used this successfully as a bladder washout on a 32-year-old woman with an ascending yeast infection associated with vaginal candidiasis which was eradicated with magmilor pessaries.
General measures should include alkalinization of the urine. Yeasts have been known to grow less readily in alkaline media (Edebo & Spetz 1965 , Streja & Zaharia 1956 . Oral antifungal agents should be given if the gut is harbouring a reservoir of yeasts causing blood borne infection of the kidneys. Recent literature reports 5fluorcytosine as an effective oral agent (Scholer 1970 , Zincke et al. 1973 ). An existing local antifungal agent BAYb 5097 (Oberste et al. 1970 ) is also undergoing clinical trials for marketing as an oral agent. Summary A case of pyelonephritis and hydronephrosis due to candida infection is presented. Predisposing factors were, age extremity, congenital renal anomalies and long-term broad spectrum antibiotics. Treatment with ampnotericin is effective when given locally in conjunction with systemic alkalizing agents.
The Adrenal Cortex and Prostatic Cancer by W B Peeling FRCS (Royal Gwent Hospital, Newport, Gwent, NPT2UB) and K Griffiths BSC PhD (The Tenovus Institutefor Cancer Research, Heath Park, Cardiff) Testosterone in the plasma of normal men is mainly of testicular origin. After treatment for prostatic cancer by orchidectomy or suppression of testosterone synthesis by administration of compounds such as diethylstilboestrol, the main source of circulating testosterone is the adrenal cortex. Indirect evidence suggests that the adrenal cortex may be involved in some way with the natural history of prostatic cancer, and the possibility exists that it may be the direct or indirect source of secondary increases of plasma testosterone that is sometimes observed after a period of endocrine treatment in some men with this disease.
Section of Urology
We have studied the patterns of response of plasma testosterone in men with prostatic cancer in relation to changes of adrenocortical function.
Clinical Material
Group 1: Fifteen newly referred patients with untreated histologically proven prostatic cancer were studied. Three received no further treatment because they were judged to suffer from asymptomatic Stage II disease. The remaining men experienced symptoms from Stage III or Stage IV disease. One of these underwent orchidectomy at his request, and the remaining 11 were treated with stilboestrol diphosphate (Honvan) 300 mg daily. Five men with advanced Stage IV disease failed to benefit from treatment and died within three to six months; 3 defaulted from follow up, and 3 attended regularly and were studied subsequently.
Group 2: Eleven patients with histologically proven prostatic cancer who had been treated with either diethylstilboestrol 15 mg a day or Honvan 300 mg a day for at least six months were studied. Three patients had been studied before treatment had commenced (from Group 1), and 3 had been castrated but had continued to take oestrogenic compounds.
Group 3: Seventeen men in whom there was no evidence of benign or malignant prostatic cancer disease were studied. Their ages ranged from 60 to 75 years.
Methods
Adrenocortical stimulation: Adrenocortical stimulation was obtained by intramuscular injection of 1 mg of Depo-Tetracosactrin (Synacthen). Each test took two daysa control day and a test day. On the control day, venous blood samples were taken at 0900 and 1600, and on the following (test) day, a blood sample taken at 0900 was immediately followed by intramuscular injection of Synacthen. A further blood sample taken at 1600 on that day completed the test. In this way, it was hoped to minimize errors due to circadian variations of the levels of the hormones that were studied. There were no complications or side effects from these procedures. Adrenocortical suppression: Two patients with prostatic cancer under treatment with Honvan 300 mg a day were treated with dexamethasone 8 mg a day for three consecutive days. Daily venous blood samples were obtained at 0900 for five/six consecutive days for hormone analysis. The patients were volunteers for this test, and there were no side effects or complications.
Results
Adrenocortical stimulation: The mean plasma testosterone levels of three groups of patients that were studied are shown in Table 1 . These observations showed that those patients with untreated prostatic cancer (Group 1) and those without evidence of prostatic disease (Group 3) exhibited a fall of mean plasma testosterone levels between 0900 and 1600 on the control day of study. This was a normal pattern and was not modified by injection of Synacthen.
Men with prostatic cancer who had received treatment with cestrogens for at least six months (Group 2) exhibited unvarying low mean plasma testosterone levels on the control day of study. After injection of Synacthen, there was a mean increase of their plasma testosterone levels by 93 ng/100 ml.
Adenocortical suppression: The plasma testosterone levels of two men with treated prostatic cancer who underwent adrenocortical suppression with dexamethasone are shown in Table 2 .
Discussion
Under normal conditions, stimulation of the adrenal cortex with ACTH does not result in increased testosterone synthesis. In this study the mean testosterone levels of men with untreated prostatic cancer and of men without evidence of prostatic disease behaved similarly and were not affected by adrenocortical stimulation with Synacthen. However, the pattern of response of testosterone in the plasma of men with treated prostatic cancer indicated an increase Table 2 Plasma testosterone levels of 2 men with treated prostatic cancer Dexamethasone Plasma testosterone ng/100 ml Day mg/day of this hormone in the circulation after adrenocortical stimulation (Table 1) . This suggests that the response of the adrenal cortex to ACTH had been modified by Honvan used to treat these men, and that the adrenal cortex under these conditions can synthesize testosterone or its precursors. This view is supported by the observation that circulating testosterone was abolished by adrenocortical suppression with dexamethasone in 2 men receiving Honvan for prostatic carcinoma (Table 2 ). These findings are of a preliminary nature and indicate that more attention should be paid to the role of the adrenal cortex in prostatic cancer, particularly relating to its influence upon the androgenic environment of the treated patient and its relation to reactivation of controlled disease.
The following papers were also read: Although the contrast media currently used for excretion urography were introduced some twenty years ago, it is only during the past decade that large doses, containing 20 g or more of iodine, have been recognized as invaluable in the investigation of urinary tract diseases. Such doses are based upon sound physiological principles (Saxton 1969), provide a consistent and excellent demonstration of the whole urinary tract and have been recommended for the diagnosis of all major groups of urinary tract disease. Despite the large number of publications detailing the side effects which may follow the intravenous injection of contrast medium, considerable confusion and misunderstanding persists regarding the incidence and variety of acute reactions, their significance in the clinical setting and their relationship to a history of allergy (Witten et al. 1973) .
A prospective study of a consecutive series of 3509 patients referred to the Department of Radiodiagnosis, Bristol Royal Infirmary was undertaken to reassess these problems and their relationship to the quantity of contrast medium given. Sodium diatrizoate (Hypaque) in 25 % and 45 % strengths, a mixture of sodium and methyglucamine diatrizoate (Urovision), and sodium iothalamate (Conray 420) were compared. Preliminary fluid restriction was used. All the relevant data was recorded on special survey sheets, transferred to punched cards and analysed using a suitable computer programme.
Results
No deaths followed excretion urography in this series, and 1287 patients experienced no side effects. The untoward effects which did occur were classified according to their impact upon the investigation and the need for treatment. Trivial reactions did not interfere with the examination and required no treatment. Minor reactions hampered or delayed the investigation but required no treatment whilst major reactions interfered with the examination and required treatment. In addition, both those effects generally accepted as allergic in nature, and those which were recognized to be due to an excess of contrast medium were separately classified as allergic and toxic respectively (Table 1) .
